CA 125 [] (ovarian cancer) AFP, LDH, [] βHCG (germ cell tumour) Monitor for response/progression in CA15-3 and CEA [] metastatic disease (breast cancer) CA 125 [] (ovarian cancer) Predict drug toxicity CYP3A4, CYP3A5, UGT1A1 [, ] lymphoblastic leukaemia) Table 1.6. Potential uses for cancer biomarkers (adapted from []).
CA 125 (ovarian cancer) [] AFP, LDH, βHCG (germ cell tumour) [] Monitor for response/progression in metastatic disease CA15-3 and CEA (breast cancer) [] CA 125 (ovarian cancer) [] Predict drug toxicity CYP3A4, CYP3A5, UGT1A1 lymphoblastic leukaemia) [, ] Table 1.6. Potential uses for cancer biomarkers (adapted from []).
THESIS%20FINAL%20DRAFT%2008JUNE2015.docx